Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

The Centers for Medicare & Medicaid Services on Friday released an informational bulletin with updated federal poverty level ...

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...